Literature DB >> 788745

Determination of the optimum dose of subcutaneous salbutamol in asthmatic patients.

T J Coady, C J Stewart, H J Davis.   

Abstract

Saline and salbutamol (250 mug, 500 mug, 750 mug, and 1000 mug) injections were administered under double-blind conditions to seven chronic stable asthmatic patients. The response on the respiratory system (FEV1, FVC) and cardiovascular system (pulse rate, blood pressure and ECG) was monitored for 3 hours. Increasing the dose of salbutamol increased the peak and weighted average effects of FEV1 and pulse rate. The optimum dose, a titration of desired increases in FEV1 and undesirable increases in pulse rate, is 500 mug but doses up to 1000 mug may be administered if necessary.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788745      PMCID: PMC1428874          DOI: 10.1111/j.1365-2125.1976.tb00598.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

2.  The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline.

Authors:  G M Cochrane; T J Clark; M E Hanan
Journal:  Curr Med Res Opin       Date:  1973       Impact factor: 2.580

Review 3.  Actions of sympathomimetic amines and their antagonists on skeletal muscle.

Authors:  W C Bowman; M W Nott
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

4.  The effect of intramuscular salbutamol in asthmatics.

Authors:  J Ingram; J Gaddie; C Skinner; K N Palmer
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

5.  Bronchodilator effect of oral salbutamol in asthmatics treated with corticosteroids.

Authors:  S S Parker; Y F Choo-Kang; E J Cooper; S J Cameron; I W Grant
Journal:  Br Med J       Date:  1971-10-16

6.  Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma.

Authors:  Y F Choo-Kang; W T Simpson; I W Grant
Journal:  Br Med J       Date:  1969-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.